Newsroom

News and safety alerts

868 items

Announcements, product safety communications and regulatory updates.

Safety Alerts

Loperamide: Risk of Acute Pancreatitis

DISCLAIMER: This publication is aimed at health professionals. The information is meant to provide updates on medication safety issues, and not as a substitute for clinical judgement. While…

Safety Alerts

Empagliflozin: Risk of Tubulointerstitial Nephritis

Overview Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated for the treatment of type 2 diabetes mellitus and prevention of cardiovascular death among type 2 diabetes…

Safety Alerts

Olmesartan: Risk of Autoimmune Hepatitis

The NPRA has updated information about this safety issue. See the NPRA Safety Alerts published on 6 May 2024. Overview Olmesartan is an angiotensin II receptor antagonist indicated for the treatment…

Safety Alerts

Azathioprine: Risk of Erythema Nodosum

Overview Azathioprine is an immunosuppressant antimetabolite that is indicated in combination with steroids and/or other immunosuppressive agents/procedures to improve the survival of organ…

Announcement

Cold Chain Facilities List

This list reflects the Cold Chain Facilities with satisfactory compliance status in Malaysia (limited to licensed importers and wholesalers) at the inspection time. It should not be relied upon to…